To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Foreign Policy.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H5908373CDBC74B549B0A88004008C3FC: 1. Short title This Act may be cited as the Plain Prescription Prices Act.
- Section H4E53BDE63EEC4881B9A7BF95E7D20FAD: 2. Regulating advertisements for prescription drug and biological product prices Not later than one year after the date of the enactment of this Act, the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Foreign Policy
Primary Purpose
This bill, To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Williams of Georgia (for herself, Mr. Bacon, Ms. Craig, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_administrator"
- → The Administrator identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology